Action of Thymoxamine on Mydriasis induced by Levodopa and Dopamine
- 22 May 1971
- Vol. 2 (5759) , 438-439
- https://doi.org/10.1136/bmj.2.5759.438
Abstract
Eye-drops of levodopa and dopamine induce pupillary dilatation which is inhibited by thymoxamine, an alpha-adrenergic blocking drug. This indicates that the mydriatic action of levodopa and dopamine involves excitation of alpha-adrenergic receptors of the dilator pupillae muscle. Such a conclusion is in accord with the previously expressed suggestion that levodopa is rapidly converted to dopamine, which displaces noradrenaline from adrenergic nerve endings. The findings that dopamine exerts alpha-adrenergic effects at the periphery may be construed as evidence in support of the view that the hypotensive action of levodopa is mediated via the central nervous system.Keywords
This publication has 10 references indexed in Scilit:
- Effect of L‐dopa alone and in combination with an extracerebral decarboxylase inhibitor on blood pressure and some cardiovascular reflexesClinical Pharmacology & Therapeutics, 1970
- Central hypotensive effect of L-3,4-dihydroxyphenylalanine in the ratJournal of Pharmacy and Pharmacology, 1970
- Pupillary Effects of Levodopa TherapyNew England Journal of Medicine, 1970
- Miosis during L-Dopa TherapyBMJ, 1970
- Hypotension Caused by L-DopaBMJ, 1970
- Action of dopamine on the human irisBMJ, 1969
- Treatment of Parkinsonism With LevodopaArchives of Neurology, 1969
- Modification of Parkinsonism — Chronic Treatment with L-DopaNew England Journal of Medicine, 1969
- Increase of Cerebral Catecholamines caused by 3,4-Dihydroxyphenylalanine after Inhibition of Peripheral DecarboxylaseNature, 1967
- Direct Renal Vasodilatation Produced by Dopamine in the DogCirculation Research, 1965